203 related articles for article (PubMed ID: 23314552)
1. Choline-containing phospholipids: relevance to brain functional pathways.
Tayebati SK; Amenta F
Clin Chem Lab Med; 2013 Mar; 51(3):513-21. PubMed ID: 23314552
[TBL] [Abstract][Full Text] [Related]
2. Choline-Containing Phospholipids: Structure-Activity Relationships Versus Therapeutic Applications.
Tayebati SK; Marucci G; Santinelli C; Buccioni M; Amenta F
Curr Med Chem; 2015; 22(38):4328-40. PubMed ID: 26511472
[TBL] [Abstract][Full Text] [Related]
3. Effect of choline-containing phospholipids on brain cholinergic transporters in the rat.
Tayebati SK; Tomassoni D; Di Stefano A; Sozio P; Cerasa LS; Amenta F
J Neurol Sci; 2011 Mar; 302(1-2):49-57. PubMed ID: 21195433
[TBL] [Abstract][Full Text] [Related]
4. Effects of choline containing phospholipids on the neurovascular unit: A review.
Roy P; Tomassoni D; Nittari G; Traini E; Amenta F
Front Cell Neurosci; 2022; 16():988759. PubMed ID: 36212684
[TBL] [Abstract][Full Text] [Related]
5. Choline alphoscerate (alpha-glyceryl-phosphoryl-choline) an old choline- containing phospholipid with a still interesting profile as cognition enhancing agent.
Traini E; Bramanti V; Amenta F
Curr Alzheimer Res; 2013 Dec; 10(10):1070-9. PubMed ID: 24156263
[TBL] [Abstract][Full Text] [Related]
6. Cholinergic precursors in the treatment of cognitive impairment of vascular origin: ineffective approaches or need for re-evaluation?
Parnetti L; Mignini F; Tomassoni D; Traini E; Amenta F
J Neurol Sci; 2007 Jun; 257(1-2):264-9. PubMed ID: 17331541
[TBL] [Abstract][Full Text] [Related]
7. The ASCOMALVA trial: association between the cholinesterase inhibitor donepezil and the cholinergic precursor choline alphoscerate in Alzheimer's disease with cerebrovascular injury: interim results.
Amenta F; Carotenuto A; Fasanaro AM; Rea R; Traini E
J Neurol Sci; 2012 Nov; 322(1-2):96-101. PubMed ID: 22959283
[TBL] [Abstract][Full Text] [Related]
8. The ASCOMALVA (Association between the Cholinesterase Inhibitor Donepezil and the Cholinergic Precursor Choline Alphoscerate in Alzheimer's Disease) Trial: interim results after two years of treatment.
Amenta F; Carotenuto A; Fasanaro AM; Rea R; Traini E
J Alzheimers Dis; 2014; 42 Suppl 3():S281-8. PubMed ID: 24898643
[TBL] [Abstract][Full Text] [Related]
9. Modulation of monoaminergic transporters by choline-containing phospholipids in rat brain.
Tayebati SK; Tomassoni D; Nwankwo IE; Di Stefano A; Sozio P; Cerasa LS; Amenta F
CNS Neurol Disord Drug Targets; 2013 Feb; 12(1):94-103. PubMed ID: 23244432
[TBL] [Abstract][Full Text] [Related]
10. Association with the cholinergic precursor choline alphoscerate and the cholinesterase inhibitor rivastigmine: an approach for enhancing cholinergic neurotransmission.
Amenta F; Tayebati SK; Vitali D; Di Tullio MA
Mech Ageing Dev; 2006 Feb; 127(2):173-9. PubMed ID: 16297435
[TBL] [Abstract][Full Text] [Related]
11. Choline and Choline alphoscerate Do Not Modulate Inflammatory Processes in the Rat Brain.
Tayebati SK; Martinelli I; Moruzzi M; Amenta F; Tomassoni D
Nutrients; 2017 Sep; 9(10):. PubMed ID: 28961195
[TBL] [Abstract][Full Text] [Related]
12. Pathways of acetylcholine synthesis, transport and release as targets for treatment of adult-onset cognitive dysfunction.
Amenta F; Tayebati SK
Curr Med Chem; 2008; 15(5):488-98. PubMed ID: 18289004
[TBL] [Abstract][Full Text] [Related]
13. Choline alphoscerate in cognitive decline and in acute cerebrovascular disease: an analysis of published clinical data.
Parnetti L; Amenta F; Gallai V
Mech Ageing Dev; 2001 Nov; 122(16):2041-55. PubMed ID: 11589921
[TBL] [Abstract][Full Text] [Related]
14. Treatment of cognitive dysfunction associated with Alzheimer's disease with cholinergic precursors. Ineffective treatments or inappropriate approaches?
Amenta F; Parnetti L; Gallai V; Wallin A
Mech Ageing Dev; 2001 Nov; 122(16):2025-40. PubMed ID: 11589920
[TBL] [Abstract][Full Text] [Related]
15. Choline production from choline-containing phospholipids: a hypothetical role in Alzheimer's disease and aging.
Maire JC; Wurtman RJ
Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(4-6):637-42. PubMed ID: 6543397
[TBL] [Abstract][Full Text] [Related]
16. Phosphatidylcholine as a precursor of choline for acetylcholine synthesis.
Blusztajn JK; Liscovitch M; Mauron C; Richardson UI; Wurtman RJ
J Neural Transm Suppl; 1987; 24():247-59. PubMed ID: 3316498
[TBL] [Abstract][Full Text] [Related]
17. CDP-choline: pharmacological and clinical review.
Secades JJ; Frontera G
Methods Find Exp Clin Pharmacol; 1995 Oct; 17 Suppl B():1-54. PubMed ID: 8709678
[TBL] [Abstract][Full Text] [Related]
18. Effect of treatment with choline alphoscerate on hippocampus microanatomy and glial reaction in spontaneously hypertensive rats.
Tomassoni D; Avola R; Mignini F; Parnetti L; Amenta F
Brain Res; 2006 Nov; 1120(1):183-90. PubMed ID: 16989788
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic applications of citicoline for stroke and cognitive dysfunction in the elderly: a review of the literature.
Conant R; Schauss AG
Altern Med Rev; 2004 Mar; 9(1):17-31. PubMed ID: 15005642
[TBL] [Abstract][Full Text] [Related]
20. Dynamics of Choline-Containing Phospholipids in Traumatic Brain Injury and Associated Comorbidities.
Javaid S; Farooq T; Rehman Z; Afzal A; Ashraf W; Rasool MF; Alqahtani F; Alsanea S; Alasmari F; Alanazi MM; Alharbi M; Imran I
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
